Exelixis Reviews

3.3
Rating Trends
Recommend to a friend
Approve of CEO
Exelixis President, CEO, and Director Michael M. Morrissey
Michael M. Morrissey
10 Ratings
  • A great experience with great people

    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Exelixis full-time (More than 5 years)

    Disapproves of CEO
    Disapproves of CEO

    Pros

    I worked with truly great people who formed a community filled with optimism and hope for a great future for Exelixis.

    Cons

    Unfortunately, that future did not come to pass.

    Advice to Management

    "Fish rots from the head down"


Exelixis Interviews

Interview Experience

Interview Experience

66%
16%
16%

Getting an Interview

Getting an Interview

60%
20%
20%

Interview Difficulty

3.1
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Senior Director Interview

    Anonymous Interview Candidate in South San Francisco, CA
    Accepted Offer
    Average Interview

    Application

    I applied through a recruiter – interviewed at Exelixis (South San Francisco, CA).

    Interview

    Very pleasant people, questions relevant for the job description. However, it took a long time until I did not hear that they will move forward to hire me. All in all, the whole interviewing process was pleasant, just a lot of uncertainty.

    Interview Questions

    Negotiation

    I did not negotiate anything I just accepted the offer as it is as the offer was fair.

Exelixis Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.exelixis.com
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1994
Type Company - Public (EXEL)
Industry Biotech & Pharmaceuticals
Revenue $25 to $50 million (USD) per year

We've come a long way, baby, but we still have a lot in common with the fruit fly. Exelixis, a pharmaceutical research and development firm, got its start analyzing genetic data from fruit flies and other organisms as a means to speed the development of drugs and other products. Its early genomic work has yielded a pipeline of drug candidates primarily in the area of cancer therapies, as well as some potential treatments for metabolic and cardiovascular diseases. The company's drug candidates in clinical trials include treatments for solid tumors, thyroid cancer ... More

Work at Exelixis? Share Your Experiences

Exelixis

 
Click to Rate
or